CN_Summer 2008
A KRAS-variant is a Biomarker of Poor Outcome, Platinum Chemotherapy Resistance and a Potential Target for Therapy in Ovarian Cancer
Natural aromatase inhibitors
Yun Hee Jang, Mario Blanco, Siddharth Dasgupta, William A. Goddard, III MSC, Beckman Institute, Caltech David A. Keire, John E. Shively The Beckman Research.
Splicing Regulations of CD44v3 in Breast Cancer Metastasis Hayley Baines City of Hope Summer Student Program May 27 – August 1, 2003 Mentor: Tracy Li,
Announcements 1. Mean on multiple choice section of exam 3 = 71% Range from 22% - 100%; 5 people didn’t take exam 3. 2. Reminder - no labs week of Thanksgiving!
Announcements
Gene Therapy & Molecular Biology Volume 8 Issue B
Gene Therapy & Molecular Biology Volume 10 Issue B
